Literature DB >> 18394954

Genetic diversity of the Kaposi's sarcoma herpesvirus K1 protein in AIDS-KS in Zimbabwe.

Tiffany White1, Moira Hagen, Ivy Gudza, Irene E White, Buxton Ndemera, Lovemore Gwanzura, Margaret Borok, Thomas B Campbell.   

Abstract

BACKGROUND: Kaposi's sarcoma-associated herpesvirus (KSHV) encodes genetically diverse K1 alleles which have unique geographic distributions. Little is known about K1 genetic diversity in Zimbabwe where acquired immunodeficiency syndrome-associated KS (AIDS-KS) is epidemic.
OBJECTIVE: Evaluate K1 diversity in Zimbabwe and compare Zimbabwean K1 diversity to other areas in Africa. STUDY
DESIGN: K1 nucleotide sequence was determined for AIDS-KS cases in Zimbabwe. K1 references sequences were obtained from Genbank.
RESULTS: Among 65 Zimbabwean AIDS-KS cases, 26 (40%) were K1 subtype A and 39 (60%) were subtype B. Zimbabwean subtype A sequences grouped only with African intratype A5 variants. Zimbabwean subtype B sequences grouped with multiple intratype African variants: 26 B1 (26%), four B3 (6%) and nine highly divergent B4 (14%). Zimbabwean subtype B had a lower synonymous to nonsynonymous mutation ratio (median 0.59 versus 0.66; P=0.008) and greater distance to the most recent common ancestor (median 0.03 versus 0.009; P<0.001) compared to subtype A. Within the B subgroup, the distribution of intratype B variants differed in Zimbabwe and Uganda (P=0.004).
CONCLUSIONS: Greater positive selection and genetic diversity in K1 subtype B compared to subtype A5 exist in Zimbabwe. However, there were no significant associations between K1 subtype and the clinical or demographic characteristics of AIDS-KS cases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394954      PMCID: PMC2556225          DOI: 10.1016/j.jcv.2008.02.006

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  19 in total

1.  High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations.

Authors:  J C Zong; D M Ciufo; D J Alcendor; X Wan; J Nicholas; P J Browning; P L Rady; S K Tyring; J M Orenstein; C S Rabkin; I J Su; K F Powell; M Croxson; K E Foreman; B J Nickoloff; S Alkan; G S Hayward
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus.

Authors:  M Lagunoff; R Majeti; A Weiss; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

3.  Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.

Authors:  H R Wabinga; D M Parkin; F Wabwire-Mangen; J W Mugerwa
Journal:  Int J Cancer       Date:  1993-04-22       Impact factor: 7.396

Review 4.  The descent of human herpesvirus 8.

Authors:  D J McGeoch; A J Davison
Journal:  Semin Cancer Biol       Date:  1999-06       Impact factor: 15.707

Review 5.  KSHV strains: the origins and global spread of the virus.

Authors:  G S Hayward
Journal:  Semin Cancer Biol       Date:  1999-06       Impact factor: 15.707

6.  Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group.

Authors:  P M Cook; D Whitby; M L Calabro; M Luppi; D N Kakoola; H Hjalgrim; K Ariyoshi; B Ensoli; A J Davison; T F Schulz
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

7.  The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors.

Authors:  Ling Wang; Naohiro Wakisaka; Christine C Tomlinson; Scott M DeWire; Stuart Krall; Joseph S Pagano; Blossom Damania
Journal:  Cancer Res       Date:  2004-04-15       Impact factor: 12.701

8.  Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8.

Authors:  J Nicholas; J C Zong; D J Alcendor; D M Ciufo; L J Poole; R T Sarisky; C J Chiou; X Zhang; X Wan; H G Guo; M S Reitz; G S Hayward
Journal:  J Natl Cancer Inst Monogr       Date:  1998

9.  Study of human herpesvirus 8 (HHV-8) variants from Kaposi's sarcoma in France: is HHV-8 subtype A responsible for more agressive tumors?

Authors:  F Boralevi; B Masquelier; M Denayrolles; M Dupon; J L Pellegrin; J M Ragnaud; H J Fleury
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

10.  The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway.

Authors:  Christine C Tomlinson; Blossom Damania
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more
  10 in total

Review 1.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

Review 2.  Multicentric Castleman disease in an HHV8-infected child born to consanguineous parents with systematic review.

Authors:  Sandrine Leroy; Despina Moshous; Olivier Cassar; Yves Reguerre; Minji Byun; Vincent Pedergnana; Danielle Canioni; Antoine Gessain; Eric Oksenhendler; Claire Fieschi; Nizar Mahlaoui; Jean-Pierre Rivière; Rose-Marie Herbigneaux; Matthias Muszlak; Jean-Pierre Arnaud; Alain Fischer; Capucine Picard; Stéphane Blanche; Sabine Plancoulaine; Jean-Laurent Casanova
Journal:  Pediatrics       Date:  2011-12-12       Impact factor: 7.124

3.  Genotypic analysis of Kaposi's sarcoma-associated herpesvirus from patients with Kaposi's sarcoma in Xinjiang, China.

Authors:  Xinxing Ouyang; Yan Zeng; Bishi Fu; Xiaowu Wang; Wei Chen; Yuan Fang; Minhua Luo; Linding Wang
Journal:  Viruses       Date:  2014-11-26       Impact factor: 5.048

Review 4.  HHV-8 Seroprevalence and Genotype Distribution in Africa, 1998⁻2017: A Systematic Review.

Authors:  Elizabeth M Etta; Doyinmola P Alayande; Lufuno G Mavhandu-Ramarumo; George Gachara; Pascal O Bessong
Journal:  Viruses       Date:  2018-08-27       Impact factor: 5.048

5.  Selected genes of Human herpesvirus-8 associated Kaposi's sarcoma among patients with Human Immunodeficiency Virus-1 and Acquired Immunodeficiency Disease Syndrome.

Authors:  Rodgers Norman Demba; Nathan Shaviya; Sylviah Mweyeli Aradi; Walter Mwanda
Journal:  Pan Afr Med J       Date:  2019-04-30

6.  Epidemiology and Genetic Variability of HHV-8/KSHV among Rural Populations and Kaposi's Sarcoma Patients in Gabon, Central Africa. Review of the Geographical Distribution of HHV-8 K1 Genotypes in Africa.

Authors:  Antony Idam Mamimandjiami; Augustin Mouinga-Ondémé; Jill-Léa Ramassamy; Délia Doreen Djuicy; Philippe V Afonso; Antoine Mahé; Jean-Bernard Lekana-Douki; Olivier Cassar; Antoine Gessain
Journal:  Viruses       Date:  2021-01-25       Impact factor: 5.048

7.  Prevalence and Risk Factors of Kaposi's Sarcoma-Associated Herpesvirus Infection among Han and Uygur Populations in Xinjiang, China.

Authors:  Zhi Wen; Wenli Li; Yuan Fang; Chang Zhou; Kang Lin; Huanwu Wu; Yiting Zhang; Yulin Zhu; Xingchen Xu; Yan Zeng; Baojing Lu; Linding Wang
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-12-31       Impact factor: 2.471

8.  Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon.

Authors:  Edouard Betsem; Olivier Cassar; Philippe V Afonso; Arnaud Fontanet; Alain Froment; Antoine Gessain
Journal:  PLoS Negl Trop Dis       Date:  2014-05-15

9.  Detection of Human Herpes Virus 8 in Kaposi's sarcoma tissues at the University Teaching Hospital, Lusaka, Zambia.

Authors:  Rabecca Tembo; Trevor Kaile; Doris Kafita; Chrispin Chisanga; Annie Kalonda; Ephraim Zulu; Mulemba Samutela; Pascal Polepole; Geoffrey Kwenda
Journal:  Pan Afr Med J       Date:  2017-06-22

Review 10.  Kaposi's Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi's Sarcoma.

Authors:  Aude Jary; Marianne Veyri; Adélie Gothland; Valentin Leducq; Vincent Calvez; Anne-Geneviève Marcelin
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.